Cost-effectiveness of different forms of intra-articular injections for the treatment of osteoarthritis of the knee
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(22):24 Advances in Therapy. 2016;33:998-1011What this means for my practice?
Euflexxa appears to be the most cost-effective hyaluronic acid product when compared to conventional care, as well as when compared to other hyaluronic acid products.
Study Summary
An single-payer economic analysis was conducted comparing 5 brands of hyaluronic acid for the treatment of knee osteoarthritis. The study evaluated the cost-effectiveness of these products compared to baseline, compared to conventional care, and compared to one another. The study found Euflexxa to be a cost-effective treatment in all of these comparisons.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
